Phase I Clinical Trial of an Intranodally Administered mRNA Based Therapeutic Vaccine Against HIV-1 Infection
AIDS - United States
doi 10.1097/qad.0000000000002026
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)